Sb Investment Advisers (Uk) LTD Vir Biotechnology, Inc. Transaction History
Sb Investment Advisers (Uk) LTD
- $13.2 Billion
- Q3 2025
A detailed history of Sb Investment Advisers (Uk) LTD transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Sb Investment Advisers (Uk) LTD holds 16,684,041 shares of VIR stock, worth $93.9 Million. This represents 0.72% of its overall portfolio holdings.
Number of Shares
16,684,041
Previous 16,684,041
-0.0%
Holding current value
$93.9 Million
Previous $84.1 Million
13.29%
% of portfolio
0.72%
Previous 0.67%
Shares
6 transactions
Others Institutions Holding VIR
# of Institutions
243Shares Held
106MCall Options Held
246KPut Options Held
126K-
Black Rock Inc. New York, NY16.4MShares$92.5 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL12.9MShares$72.7 Million32.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$72.1 Million0.0% of portfolio
-
State Street Corp Boston, MA5.24MShares$29.5 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.98MShares$16.8 Million0.0% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $747M
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...